HVC
Healthcare Value Capital Portfolio holdings
AUM
$38.5M
This Quarter Return
+8.59%
1 Year Return
+22.29%
3 Year Return
+31.09%
5 Year Return
+125.72%
10 Year Return
–
AUM
$24.8M
AUM Growth
+$24.8M
(-40%)
Cap. Flow
-$14.8M
Cap. Flow
% of AUM
-59.5%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
12
New
–
Increased
1
Reduced
1
Closed
3
Top Buys
| 1 |
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
|
$678K |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$7.72M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$7.32M |
| 3 |
Viking Therapeutics
VKTX
|
$383K |
| 4 |
SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
|
$31K |
Sector Composition
| 1 | Healthcare | 86.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TYME
1
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $8.02M | 31.19% | 2,175,000 | – | – |
|
2
Standard BioTools
LAB
$481M
| $3.88M | 15.08% | 450,000 | – | – |
|
3
GSK
GSK
$79.9B
| $3.82M | 14.85% | 100,000 | – | – |
|
4
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.47M
| $3.45M | 13.41% | 150,000 | – | – |
|
|
AGN
5
DELISTED
Allergan plc
AGN
| $2.67M | 10.39% | 20,000 | – | – |
|
|
NVLN
6
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $1.55M | 6.02% | 1,800,000 +788,513 | +78% | +$678K |
|
|
7
Viking Therapeutics
VKTX
$3.04B
| $765K | 2.97% | 100,000 -50,000 | -33% | -$383K |
|
|
ATRS
8
DELISTED
Antares Pharma, Inc.
ATRS
| $680K | 2.64% | 250,000 | – | – |
|
|
AMRN
9
Amarin Corp
AMRN
$311M
| – | – | -450,000 | Closed | -$7.32M |
|
|
10
Gilead Sciences
GILD
$140B
| – | – | -100,000 | Closed | -$7.72M |
|
|
SEEL
11
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| – | – | -100,000 | Closed | -$31K |
|
|
LCI
12
DELISTED
Lannett Company, Inc.
LCI
| – | – | 0 | – | – |
|